Standout Papers

Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines 2023 2026 2024134
  1. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines (2023)
    Xuexiang Han, Mohamad‐Gabriel Alameh et al. Nature Nanotechnology

Immediate Impact

5 by Nobel laureates 4 from Science/Nature 55 standout
Sub-graph 1 of 24

Citing Papers

Multidrug-resistant Gram-negative bacterial infections
2025 Standout
mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
1 intermediate paper

Works of James J. Knox being referenced

Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
2023 StandoutNobel
mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
2022 Nobel
and 1 more

Author Peers

Author Last Decade Papers Cites
James J. Knox 446 158 160 182 20 780
Martina Protschka 454 100 163 170 25 855
Johannes Möst 419 148 149 182 31 943
Alan Bénard 275 170 190 172 27 740
Adriana Baz Morelli 523 146 154 278 30 937
Philippa Hillyer 388 133 280 184 18 804
A. Negro Ponzi 394 180 193 104 27 855
Motohide Ichino 441 85 133 238 23 770
Vijaya Nagabhushanam 324 239 270 101 14 722
Benedikt Strunz 481 78 207 84 24 745
Meryem Aloulou 559 75 78 182 22 780

All Works

Loading papers...

Rankless by CCL
2026